» Authors » Beth A Virnig

Beth A Virnig

Explore the profile of Beth A Virnig including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 170
Citations 4802
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
McFalls M, Virnig B, Andrew Ryan M, Erickson D, Kim H, Jarosek S, et al.
J Occup Environ Med . 2025 Feb; PMID: 39971894
Objective: Older adults may pay healthcare-related costs for work injuries if Medicare covers claims over workers' compensation (WC). We assessed Medicare enrollee costs after a work-related injury by WC status.Methods:...
2.
Munger M, Cady R, Shippee N, Beebe T, Novacheck T, Virnig B
Dev Med Child Neurol . 2024 Oct; PMID: 39412081
Aim: To investigate non-clinical factors that affect health-related decision-making in mothers with young ambulatory children living with cerebral palsy (CP). Method: Guided by phenomenology, we asked parents to describe early...
3.
Nikpay S, Leeberg M, Kozhimannil K, Ward M, Wolfson J, Graves J, et al.
Health Serv Res . 2024 Sep; 60(1):e14367. PMID: 39256893
Objective: To develop a method of consistently identifying interfacility transfers (IFTs) in Medicare Claims using patients with ST-Elevation Myocardial Infarction (STEMI) as an example. Data Sources/study Setting: 100% Medicare inpatient...
4.
Shearer R, Bart G, Beebe T, Virnig B, Shippee N, Winkelman T
J Subst Use Addict Treat . 2024 Sep; 167:209505. PMID: 39241929
Introduction: Despite effective medications for opioid use disorder (MOUD), treatment engagement remains low. As the overdose crisis is increasingly characterized by opioids co-used with other substances, it is important to...
5.
Tang H, Lu Y, Okun M, Donahoo W, Ramirez-Zamora A, Wang F, et al.
Mov Disord . 2024 Aug; 39(11):1960-1970. PMID: 39189078
Background: Previous studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may have a disease-modifying effect in the development of Parkinson's disease (PD), but population studies yielded inconsistent results. Objective:...
6.
Shearer R, Shippee N, Virnig B, Beebe T, Winkelman T
Drug Alcohol Depend Rep . 2024 Feb; 10:100219. PMID: 38356919
Introduction: The US overdose crisis is increasingly characterized by opioid and methamphetamine co-use. Hospitalization is an important opportunity to engage patients in substance use treatment. Understanding characteristics of co-use-related hospital...
7.
Shearer R, Hernandez E, Beebe T, Virnig B, Bart G, Winkelman T, et al.
Subst Use Addctn J . 2024 Jan; 45(2):250-259. PMID: 38258816
Background: The overdose crisis is increasingly characterized by opioid and stimulant co-use. Despite effective pharmacologic treatment for both opioid use disorder (OUD) and contingency management for stimulant use disorders, most...
8.
Tang H, Lu Y, Okun M, Donahoo W, Ramirez-Zamora A, Wang F, et al.
Mov Disord Clin Pract . 2023 Nov; 10(11):1659-1665. PMID: 37982117
Background: The association between newer classes of glucose-lowering drugs (GLDs) and the risk of Parkinson's disease (PD) remains unclear. Objective: The aim was to examine the effect of newer GLDs...
9.
Qin X, Huckfeldt P, Abraham J, Yee D, Virnig B
Med Care . 2023 Jul; 61(9):611-618. PMID: 37440716
Background: Medicare and Medicaid dually eligible beneficiaries (duals) could experience Medicaid coverage changes without losing Medicaid. It is unknown whether health care use and clinical outcomes among elderly duals with...
10.
Munger M, Shippee N, Beebe T, Novacheck T, Virnig B
Dev Med Child Neurol . 2023 Jul; 66(1):70-81. PMID: 37431682
Aim: To evaluate the factor structure of the 49 goal prioritization questions of the Gait Outcome Assessment List (GOAL). Method: This was a retrospective review of 622 consecutive individuals diagnosed...